Bio-Gene Technology
Chemicals & Related Products · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Collins St L 6, Melbourne, Victoria,...Phone Number
+61 390681062Website
www.bio-gene.com.auRevenue
<$5 MillionStock Symbol
BGTIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Bio-Gene Technology
About Bio-Gene Technology Limited (http://www.bio-gene.com.au) Bio-Gene is an Australian public non listed biotechnology company based in Melbourne, Australia. It is developing a patent protected product platform as a new class of insecticides based on the -triketone chemical class. The insecticidal properties of this chemical class was first discovered following a botanical screening program looking to identify natural product based insecticides in Australian flora. Bio-Gene's lead molecule FLAVOCIDE is chemically synthesised nature identical flavesone.Explore more
Bio-Gene Technology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bio-Gene Technology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Bio-Gene Technology
Product Launch: Get notified when Bio-Gene Technology launches new products
Check if Bio-Gene Technology has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Bio-Gene Technology has new funding data
Earning: See what the market has to say on Bio-Gene Technology recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Bio-Gene Technology is spiking on competitors!
Click to see if Bio-Gene Technology had a recent Job posting/layoffs
Bio-Gene Technology, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Bio-Gene Technology as Masked Content
Find 3 more new buyers
Compare Similar Companies to Bio-Gene Technology
Compare insights from companies similar to Bio-Gene Technology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bio-Gene Technology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bio-Gene Technology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bio-Gene Technology.
Bio-Gene Technology financials insights
Gather financial insights about Bio-Gene Technology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$2.4M
Bio-Gene Technology Tech Stack
A closer look at the technologies used by Bio-Gene Technology
See more technologies
Most Recent Scoops
Project
anticipates receiving preliminary data from the OECD 424 neurotoxicity study for Flavocide later this month, with results from the OECD 443 one-generation reproductive toxicology study expected in September.
Medical Research
Project
Bio-Gene Technology has obtained an OMRI (Organic Materials Review Institute) organic listing for Qcide in the US, recognizing the product's 100% natural, steam-distilled production process as compliant with organic certification standards.
Project
Bio-Gene Technology is working to scale up Qcide production capacity, noting an approximately 18-month lead time from seed germination to first oil offtake, with plans to potentially extend its early-to-market strategy to additional territories subject to sufficient production capacity.
Capacity Planning, Manufacturing Operations
Project
Bio-Gene Technology has announced plans to expand Qcide distribution in Japan into approximately 4,000 large hardware stores and approximately 2,000 large pharmacy chains following initial online sales, with first Qcide supply shipments expected in Q3 and the formal product launch and first online sales anticipated in Q4.
Business Development
Product Launch
Bio-Gene Technology News & Media
Bio-Gene Technology First Half 2023 Earnings: AU$0.012 loss per share (vs AU$0.01 loss in 1H 2022)
Bio-Gene Technology ( ASX:BGT ) First Half 2023 Results Key Financial Results Net loss: AU$1.97m (loss widened by 37...We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...We Think Bio-Gene Technology (ASX:BGT) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...Bio-Gene Technology (ASX:BGT) raises $2.4M as part of capital initiative
Bio-Gene Technology (ASX:BGT) has received firm commitments to raise $2.4 million through a share placement to sophisticated and professional investors.
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Bio-Gene Technology
Sign Up For FreeTo access detailed company insights
About Bio-Gene Technology Limited (http://www.bio-gene.com.au) Bio-Gene is an Australian public non listed biotechnology company based in Melbourne, Australia. It is developing a patent protected product platform as a new class of insecticides based on the -triketone chemical class. The insecticidal properties of this chemical class was first disco... Read More
